GayathriNagarajMD
Oncology • Loma Linda, CABreast Cancer, Hematologic Oncology
Associate Professor of Medicine Program Director, Hematology/Oncology Fellowship Loma Linda University School of Medicine
Dr. Nagaraj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11234 Anderson St
Schuman Pavilion Room A600
Loma Linda, CA 92354Phone+1 909-558-2262Fax+1 909-651-5939
Summary
- Dr. Gayathri Nagaraj is an oncologist in Loma Linda, CA and is affiliated with Loma Linda University Medical Center. She received her medical degree from Bangalore Medical College and has been in practice 15 years. She specializes in hematologic oncology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2005 - 2008
Bangalore Medical CollegeClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2025
MO State Medical License 2009 - 2012
PA State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1211 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20 - 70 citationsCOVID-19 vaccination and breakthrough infections in patients with cancer.A L Schmidt, C Labaki, C-Y Hsu, Z Bakouny, N Balanchivadze
Annals of Oncology. 2022-03-01 - 36 citationsConservative management of nivolumab-induced pericardial effusion: a case report and review of literatureShagufta Shaheen, Hamid R. Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Experimental Hematology & Oncology. 2018-05-08
Press Mentions
Woman Overcomes Breast Cancer Again, and Again, and AgainOctober 26th, 2021- Study: Demographic Factors Associated with Poorer Outcomes in Cancer Patients Who Contract COVID-19March 23rd, 2021
Woman Diagnosed with Breast Cancer During Pregnancy Gave Birth to ‘Miracle Baby’March 30th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
